Escobar Cervantes, Carlos; Martí Almor, Julio; Pérez Cabeza, Alejandro Isidoro; Bowrin, Kevin; Llorac Moix, Aleix; Genís Gironès, Mar; Gasche, David; Aurélie, Millier; Tardu, Jean; Toumi, Mondher; Briere, Jean-Baptiste
(Public Library of Science (PLoS), 2022)
Aims: a Markov model was adapted to assess the real-world cost-effectiveness of rivaroxaban, dabigatran and apixaban. Each of these non-vitamin K antagonist oral anticoagulants was compared with vitamin K antagonist for ...